107 related articles for article (PubMed ID: 9469645)
1. Effects of Kamikihi-To, a traditional Chinese medicine, on behavioral changes induced by methyl-beta-carboline-3-carboxylate in mice and rats.
Nishizawa K; Yamashita A
Jpn J Pharmacol; 1997 Dec; 75(4):391-7. PubMed ID: 9469645
[TBL] [Abstract][Full Text] [Related]
2. beta-CCM inhibits muricide induced by olfactory bulbectomy in rats.
Nagatani T; Yamamoto T; Takao K; Sugihara T; Ueki S
Jpn J Pharmacol; 1990 Mar; 52(3):441-7. PubMed ID: 2159079
[TBL] [Abstract][Full Text] [Related]
3. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice.
Takeda H; Tsuji M; Matsumiya T
Eur J Pharmacol; 1998 May; 350(1):21-9. PubMed ID: 9683010
[TBL] [Abstract][Full Text] [Related]
4. Effects of diazepam and beta-CCM on working memory in mice: relationships with emotional reactivity.
Krazem A; Borde N; Béracochéa D
Pharmacol Biochem Behav; 2001 Feb; 68(2):235-44. PubMed ID: 11267628
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of kamikihi-to, a traditional Chinese medicine, against cerebral ischemia, hypoxia and anoxia in mice and gerbils.
Nishizawa K; Inoue O; Saito Y; Suzuki A
Jpn J Pharmacol; 1994 Mar; 64(3):171-7. PubMed ID: 8022119
[TBL] [Abstract][Full Text] [Related]
6. Behavioural and convulsant actions of two methyl esters of beta-carboline-3-carboxylic acid in photosensitive baboons and in DBA/2 mice.
Croucher M; De Sarro G; Jensen L; Meldrum B
Eur J Pharmacol; 1984 Sep; 104(1-2):55-60. PubMed ID: 6499918
[TBL] [Abstract][Full Text] [Related]
7. Divergent levels of anxiety in mice selected for differences in sensitivity to a convulsant agent.
Suaudeau C; Rinaldi D; Lepicard E; Venault P; Crusio WE; Costentin J; Chapouthier G
Physiol Behav; 2000 Dec; 71(5):517-23. PubMed ID: 11239670
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of methyl- and propyl-beta-carbolines in a hereditary model of epilepsy.
Johnson DD; Fisher TE; Tuchek JM; Crawford RD
Neuropharmacology; 1984 Sep; 23(9):1015-7. PubMed ID: 6151141
[TBL] [Abstract][Full Text] [Related]
9. The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice.
Burkard WP; Bonetti EP; Haefely W
Eur J Pharmacol; 1985 Feb; 109(2):241-7. PubMed ID: 2986997
[TBL] [Abstract][Full Text] [Related]
10. The effect of agonists at the GABA-benzodiazepine-receptor-complex on the proconflict effect induced by beta-CCM and pentetrazol in rats.
Nagatani T; Yamamoto T; Sugihara T; Ueki S
Jpn J Pharmacol; 1988 Mar; 46(3):267-74. PubMed ID: 2837602
[TBL] [Abstract][Full Text] [Related]
11. Antagonism by propyl-beta-carboline-3-carboxylate of passive avoidance impairment induced by diazepam.
Nagatani T; Yamamoto T
Eur J Pharmacol; 1991 May; 198(1):109-12. PubMed ID: 1915575
[TBL] [Abstract][Full Text] [Related]
12. Effects of Kamikihi-To, a traditional Chinese medicine, on passive and conditioned avoidance performance impairment in senescence accelerated mouse (SAM).
Nishizawa K; Saito H; Nishiyama N
Jpn J Pharmacol; 1990 Dec; 54(4):375-82. PubMed ID: 2086999
[TBL] [Abstract][Full Text] [Related]
13. Interactions of Ginkgo biloba extract (EGb 761), diazepam and ethyl beta-carboline-3-carboxylate on social behavior of the rat.
Chermat R; Brochet D; DeFeudis FV; Drieu K
Pharmacol Biochem Behav; 1997 Feb; 56(2):333-9. PubMed ID: 9050093
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
[TBL] [Abstract][Full Text] [Related]
15. The effects of methyl beta-carboline-3-carboxylate on social interaction and locomotor activity when microinjected into the nucleus raphé dorsalis of the rat.
Hindley SW; Hobbs A; Paterson IA; Roberts MH
Br J Pharmacol; 1985 Nov; 86(3):753-61. PubMed ID: 3933600
[TBL] [Abstract][Full Text] [Related]
16. Characterization of convulsions induced by methyl beta-carboline-3-carboxylate in mice.
Prado de Carvalho L; Grecksch G; Cavalheiro EA; Dodd RH; Chapouthier G; Rossier J
Eur J Pharmacol; 1984 Aug; 103(3-4):287-93. PubMed ID: 6436041
[TBL] [Abstract][Full Text] [Related]
17. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
Yang XM; Luo ZP; Zhou JH
J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863
[TBL] [Abstract][Full Text] [Related]
18. The benzodiazepine receptor ligand, methyl beta-carboline-3-carboxylate, is both sedative and proconvulsant in chicks.
Venault P; Prado de Carvalho L; Brown CL; Dodd RH; Rossier J; Chapouthier G
Life Sci; 1986 Sep; 39(12):1093-100. PubMed ID: 3018410
[TBL] [Abstract][Full Text] [Related]
19. Socio-psychological stress-induced antinociception in diabetic mice.
Kamei J; Ohsawa M
Psychopharmacology (Berl); 2000 May; 149(4):397-400. PubMed ID: 10867967
[TBL] [Abstract][Full Text] [Related]
20. Mouse lines differing in sensitivity to beta-CCM differ in tasks used for testing antidepressants.
Do-Rego JC; Suaudeau C; Chapouthier G; Costentin J
Pharmacol Biochem Behav; 2002 May; 72(1-2):411-6. PubMed ID: 11900813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
